Yuarn-Jang Lee

Yuarn-Jang Lee

Auto-generated profile, based on publicly available information

Yuarn-Jang Lee

Division of Infectious Disease, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CWChang Yi Wang
Chang Yi Wang
KHKao-Pin Hwang
Kao-Pin Hwang
HKHui-Kai Kuo
Hui-Kai Kuo
WPWen-Jiun Peng
Wen-Jiun Peng
YSYea-Huei Shen
Yea-Huei Shen
TMThomas Monath
Thomas Monath
Background. The Delta and Omicron variants of SARS-CoV-2 are currently responsible for breakthrough infections due to waning immunity. We report phase I/II trial results of UB-612, a multitope subunit vaccine containing S1-RBD-sFc protein and rationally designed promiscuous peptides representing sarbecovirus conserved helper T cell and cytotoxic T lymphocyte epitopes on the nucleocapsid (N), membrane (M), and spike (S2) proteins. Method. We conducted a phase I primary 2-dose (28 days apart) trial of 10, 30, or 100 μg UB-612 in 60 healthy young adults 20 to 55 years old, and 50 of them were boosted with 100 μg of UB-612 approximately 7 to 9 months after the second dose. A separate placebo-controlled and randomized phase II study was conducted with 2 doses of 100 μg of UB-612 (n = 3,875, 18–85 years old). We evaluated interim safety and immunogenicity of phase I until 14 days after the third (booster) dose and of phase II until 28 days after the second dose. Results. No vaccine-related serious adverse events were recorded. The most common solicited adverse events were injection site pain and fatigue, mostly mild and transient. In both trials, UB-612 elicited respective neutralizing antibody titers similar to a panel of human convalescent sera. The most striking findings were long-lasting virus-neutralizing antibodies and broad T cell immunity against SARS-CoV-2 variants of concern (VoCs), including Delta and Omicron, and a strong booster-recalled memory immunity with high cross-reactive neutralizing titers against the Delta and Omicron VoCs. Conclusion. UB-612 has presented a favorable safety profile, potent booster effect against VoCs, and long-lasting B and broad T cell immunity that warrants further development for both primary immunization and heterologous boosting of other COVID-19 vaccines. Trial Registration. ClinicalTrials.gov: NCT04545749, NCT04773067, and NCT04967742. Funding. UBI Asia, Vaxxinity Inc., and Taiwan Centers for Disease Control, Ministry of Health and Welfare.

1 February 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
CYCheng-Yi Yang
Cheng-Yi Yang
RCRay-Jade Chen
Ray-Jade Chen
WCWan-Lin Chou
Wan-Lin Chou
YLYuarn-Jang Lee
Yuarn-Jang Lee
YLYu-Sheng Lo
Yu-Sheng Lo
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Influenza is a leading global cause of death and contributes to heavy economic losses to individuals and communities. Early prediction of and interventions against influenza epidemics are essential to reduce mortality and morbidity. As in other countries, the Taiwan Centers for Disease Control and Prevention (TWCDC) has implemented influenza surveillance and reporting systems, which mainly rely on influenza-like illness (ILI) data reported by healthcare providers for early prediction of influenza epidemics. However, these surveillance and reporting systems have at least a 2-week delay, leaving room for improvement. Objective: We aimed to integrate the TWCDC’s ILI data with the electronic medical records (EMRs) of multiple Taiwan hospitals. Our overall goal in doing so was to develop a more accurate and efficient tool for national influenza trend prediction than that available currently. Methods: First, surveillance variables relevant to the prediction of influenza epidemics were identified by the influenza expertise team at the Taipei Medical University Healthcare System (TMUHcS). Second, we developed a framework for integrating hospital EMR data with the ILI data from the TWCDC website. Third, we used Pearson correlation coefficients to measure the strength of the linear relationship between the TMUHcS’s EMR data and TWCDC’s ILI data (including regional and national ILI data) for two weekly time series datasets. Lastly, we evaluated the predictive power of each surveillance variable for influenza epidemics using the Moving Epidemic Method (MEM) analyzes. Results: For the past three influenza seasons (October 2014 to September 2017), three surveillance variables (TMUHcS-ILI, TMUHcS-RITP, and TMUHcS-IMU, reflecting patients with ILI, those with positive results from rapid influenza diagnostic tests, and those treated with antiviral drugs, respectively) were identified from the EMRs of multiple hospitals and showed strong correlations with the TWCDC’s regional and national ILI data (r = 0.86–0.98). Two surveillance variables (TMUHcS-RITP and TMUHcS-IMU) showed predictive power for influenza epidemics 3–4 weeks prior to an increase in TWCDC ILI reports. Conclusions: This framework integrates surveillance data from multiple hospitals and the TWCDC website. It could be easily extended to other infectious diseases, mitigating the time and effort required for data collection and analysis. Furthermore, this approach could be developed as a cost-effective electronic surveillance tool for early and accurate prediction of epidemics of influenza as well as other infectious diseases in densely populated regions and nations.

23 September 2021 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
SHShao-Lun Hsu
Shao-Lun Hsu
CWChin-Ting Wu
Chin-Ting Wu
YCYuan-Chen Chang
Yuan-Chen Chang
CFChia-Kwung Fan
Chia-Kwung Fan
YLYuarn-Jang Lee
Yuarn-Jang Lee
Background: Actinomyces odontolyticus is not commonly recognized as a causative microbe of liver abscess. The detection and identification of A. odontolyticus in laboratories and its recognition as a pathogen in clinical settings can be challenging. However, in the past decades, knowledge on the clinical relevance of A. odontolyticus is gradually increasing. A. odontolyticus is the dominant oropharyngeal flora observed during infancy [Li et al. in Biomed Res Int 2018:3820215, 2018]. Herein we report a case of severe infection caused by A. odontolyticus in an immunocompromised patient with disruption of the gastrointestinal (GI) mucosa. Case presentation: We present a unique case of a patient with human immunodeficiency virus infection who was admitted due to liver abscess and was subsequently diagnosed as having coinfection of A. odontolyticus, Streptococcus constellatus, and Candida albicans during the hospital course. The empirical antibiotics metronidazole and ceftriaxone were replaced with the intravenous administration of fluconazole and ampicillin. However, the patient’s condition deteriorated, and he died 3 weeks later. Conclusion: This report is one of the first to highlight GI tract perforation and its clinical relevance with A. odontolyticus infection. A. odontolyticus infection should be diagnosed early in high-risk patients, and increased attention should be paid to commensal flora infection in immunocompromised individuals.

12 March 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
CYCheng-Yi Yang
Cheng-Yi Yang
RCRay-Jade Chen
Ray-Jade Chen
WCWan-Lin Chou
Wan-Lin Chou
YLYuarn-Jang Lee
Yuarn-Jang Lee
YLYu-Sheng Lo
Yu-Sheng Lo
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

14 February 2019 in JMIR Preprints
Verified
Preprint
Open access
CYCheng-Yi Yang
Cheng-Yi Yang
RCRay-Jade Chen
Ray-Jade Chen
WCWan-Lin Chou
Wan-Lin Chou
YLYuarn-Jang Lee
Yuarn-Jang Lee
YLYu-Sheng Lo
Yu-Sheng Lo
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

29 September 2018 in JMIR Preprints
Verified
Preprint
Open access
CYCheng-Yi Yang
Cheng-Yi Yang
RCRay-Jade Chen
Ray-Jade Chen
WCWan-Lin Chou
Wan-Lin Chou
YLYuarn-Jang Lee
Yuarn-Jang Lee
YLYu-Sheng Lo
Yu-Sheng Lo
BACKGROUND Influenza is a leading cause of death worldwide and contributes to heavy economic losses to individuals and communities. Therefore, the early prediction of and interventions against influenza epidemics are crucial to reduce mortality and morbidity because of this disease. Similar to other countries, the Taiwan Centers for Disease Control and Prevention (TWCDC) has implemented influenza surveillance and reporting systems, which primarily rely on influenza-like illness (ILI) data reported by health care providers, for the early prediction of influenza epidemics. However, these surveillance and reporting systems show at least a 2-week delay in prediction, indicating the need for improvement. OBJECTIVE We aimed to integrate the TWCDC ILI data with electronic medical records (EMRs) of multiple hospitals in Taiwan. Our ultimate goal was to develop a national influenza trend prediction and reporting tool more accurate and efficient than the current influenza surveillance and reporting systems. METHODS First, the influenza expertise team at Taipei Medical University Health Care System (TMUHcS) identified surveillance variables relevant to the prediction of influenza epidemics. Second, we developed a framework for integrating the EMRs of multiple hospitals with the ILI data from the TWCDC website to proactively provide results of influenza epidemic monitoring to hospital infection control practitioners. Third, using the TWCDC ILI data as the gold standard for influenza reporting, we calculated Pearson correlation coefficients to measure the strength of the linear relationship between TMUHcS EMRs and regional and national TWCDC ILI data for 2 weekly time series datasets. Finally, we used the Moving Epidemic Method analyses to evaluate each surveillance variable for its predictive power for influenza epidemics. RESULTS Using this framework, we collected the EMRs and TWCDC ILI data of the past 3 influenza seasons (October 2014 to September 2017). On the basis of the EMRs of multiple hospitals, 3 surveillance variables, TMUHcS-ILI, TMUHcS-rapid influenza laboratory tests with positive results (RITP), and TMUHcS-influenza medication use (IMU), which reflected patients with ILI, those with positive results from rapid influenza diagnostic tests, and those treated with antiviral drugs, respectively, showed strong correlations with the TWCDC regional and national ILI data (r=.86-.98). The 2 surveillance variables—TMUHcS-RITP and TMUHcS-IMU—showed predictive power for influenza epidemics 3 to 4 weeks before the increase noted in the TWCDC ILI reports. CONCLUSIONS Our framework periodically integrated and compared surveillance data from multiple hospitals and the TWCDC website to maintain a certain prediction quality and proactively provide monitored results. Our results can be extended to other infectious diseases, mitigating the time and effort required for data collection and analysis. Furthermore, this approach may be developed as a cost-effective electronic surveillance tool for the early and accurate prediction of epidemics of influenza and other infectious diseases in densely populated regions and nations.